These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24096536)

  • 1. Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.
    Georgiadou G; Grivas V; Tarantilis PA; Pitsikas N
    Psychopharmacology (Berl); 2014 Feb; 231(4):717-26. PubMed ID: 24096536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of sub-effective doses of the constituents of Crocus sativus L. crocins with those of the antipsychotics clozapine and risperidone counteract memory deficits caused by blockade of the NMDA receptor in rats.
    Vartzoka F; Parlantza MA; Tarantilis PA; Pitsikas N
    Phytother Res; 2024 Aug; 38(8):4140-4150. PubMed ID: 39031890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crocins, the active constituents of Crocus sativus L., counteracted apomorphine-induced performance deficits in the novel object recognition task, but not novel object location task, in rats.
    Pitsikas N; Tarantilis PA
    Neurosci Lett; 2017 Mar; 644():37-42. PubMed ID: 28216334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocins, the Bioactive Components of
    Pitsikas N; Tarantilis PA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33498440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
    Trevlopoulou A; Touzlatzi N; Pitsikas N
    Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats.
    Zoupa E; Gravanis A; Pitsikas N
    Neuropharmacology; 2019 Jun; 151():74-83. PubMed ID: 30959020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the active constituents of Crocus sativus L. crocins and their combination with memantine on recognition memory in rats.
    Pitsikas N; Tarantilis PA
    Behav Pharmacol; 2018 Aug; 29(5):400-412. PubMed ID: 29462109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats' memory.
    Pitsikas N; Zisopoulou S; Tarantilis PA; Kanakis CD; Polissiou MG; Sakellaridis N
    Behav Brain Res; 2007 Nov; 183(2):141-6. PubMed ID: 17628713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia.
    Lafioniatis A; Orfanidou MA; Papadopoulou ES; Pitsikas N
    Behav Brain Res; 2016 Aug; 309():14-21. PubMed ID: 27132765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder.
    Georgiadou G; Tarantilis PA; Pitsikas N
    Neurosci Lett; 2012 Oct; 528(1):27-30. PubMed ID: 22985509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety.
    Pitsikas N; Boultadakis A; Georgiadou G; Tarantilis PA; Sakellaridis N
    Phytomedicine; 2008 Dec; 15(12):1135-9. PubMed ID: 18693098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat.
    Katsanou L; Fragkiadaki E; Kampouris S; Konstanta A; Vontzou A; Pitsikas N
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil but not bicuculline counteract the impairing effects of anesthetic ketamine on recognition memory in rats. Evidence for a functional interaction between the GABA
    Lafioniatis A; Bermperian VC; Pitsikas N
    Neuropharmacology; 2019 Apr; 148():87-95. PubMed ID: 30597159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat.
    Boultadakis A; Pitsikas N
    Neuropsychopharmacology; 2010 Nov; 35(12):2357-66. PubMed ID: 20664579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GABA
    Pitsikas N; Tarantilis PA
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel dehydroepiandrosterone derivative BNN27 counteracts the impairing effects of anesthetic ketamine on rats' non-spatial and spatial recognition memory.
    Pitsikas N; Zoupa E; Gravanis A
    Behav Brain Res; 2022 Jul; 430():113937. PubMed ID: 35644273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
    Pitsikas N; Zisopoulou S; Pappas I; Sakellaridis N
    Behav Brain Res; 2008 Apr; 188(2):304-9. PubMed ID: 18164078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nicotinic α7 receptor agonist GTS-21 but not the nicotinic α4β2 receptor agonist ABT-418 attenuate the disrupting effects of anesthetic ketamine on recognition memory in rats.
    Pitsikas N
    Behav Brain Res; 2020 Sep; 393():112778. PubMed ID: 32579977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects.
    Białoń M; Żarnowska M; Antkiewicz-Michaluk L; Wąsik A
    Psychopharmacology (Berl); 2020 Jun; 237(6):1577-1593. PubMed ID: 32076746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.